Home » Drug Information » FDA-Approved Drugs » 1999
Medical Areas: Oncology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: GlaxoSmithKline
Approval Status: Approved January 1999
Treatment Area: Oncology
Zofran ODT (odansetron) Orally Disintegrating Tablets have been
approved for prevention of chemotherapy and radiation-induced
nausea and vomiting, and prevention of postoperative nausea and
vomiting.